YD Bio director files initial insider Form 3

YD Bio Ltd director Chang Kochi filed an initial Form 3 reporting status as an insider of YD Bio Ltd (ticker YDES).

Rhea-AI Filing Summary

YD Bio Ltd director Chang Kochi filed an initial Form 3 reporting status as an insider of YD Bio Ltd (ticker YDES). The filing lists Kochi as a director and not a ten percent owner. No share transactions or derivative holdings are reported in this disclosure.

Key Terms

Form 3, reporting persons, ten percent owner

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting persons regulatory

""reportingPersons": [ { "name": "Chang Kochi""

ten percent owner financial

""is_ten_percent_owner": 0"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the YD Bio Ltd (YDES) Form 3 for Chang Kochi show?

The Form 3 shows that Chang Kochi is a director of YD Bio Ltd and now a reporting insider. It does not list any share transactions or derivative positions, serving as an initial ownership status disclosure.

Did Chang Kochi buy or sell YD Bio Ltd (YDES) shares in this Form 3?

No, this Form 3 for Chang Kochi reports zero transactions. The transaction summary indicates no buys, sells, exercises, gifts, or restructurings, meaning the filing only establishes insider status without reporting trading activity.

Does the YD Bio Ltd (YDES) Form 3 disclose any derivative securities for Chang Kochi?

No, the filing’s derivativeSummary is empty, and derivativeTransactionCount is zero. This means no options, warrants, or other derivative holdings are disclosed for Chang Kochi in this initial ownership statement.

Is Chang Kochi reported as a ten percent owner of YD Bio Ltd (YDES)?

No, the Form 3 lists is_ten_percent_owner as 0, indicating Chang Kochi is not reported as owning ten percent or more of YD Bio Ltd. The role identified is director, not large shareholder.

What is the purpose of this Form 3 for YD Bio Ltd (YDES)?

This Form 3 serves as an initial statement of beneficial ownership for director Chang Kochi. It formally records insider status with the SEC, even though it reports no specific share holdings or recent transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 07:27 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Chang Kochi

(Last) (First) (Middle)

C/O YD BIO LIMITED

12F., NO. 3, XINGNAN ST., NANGANG DIST.

(Street)

TAIPEI CITY 115001

(City) (State) (Zip)

TAIWAN

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
YD Bio Ltd [ YDES ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Kochi Chang	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)